Cargando…

Immunostaining of p16(INK4a)/Ki-67 and L1 Capsid Protein on Liquid-based Cytology Specimens Obtained from ASC-H and LSIL-H Cases

Background: Atypical squamous cell cannot exclude high-grade squamous intraepithelial lesion (ASC-H) and low-grade intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) are ambiguous diagnostic entities for the prediction of high-grade cervical lesion. Objective a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Byun, Seung Won, Lee, Ahwon, Kim, Suyeon, Choi, Yeong Jin, Lee, Youn Soo, Park, Jong Sup
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2013
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804785/ https://www.ncbi.nlm.nih.gov/pubmed/24151431 http://dx.doi.org/10.7150/ijms.6526

Ejemplares similares

Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePath™ specimens with review of literature
por: Shidham, Vinod B, et al.
Publicado: (2007)

Squamous intraepithelial lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda System
por: Alrajjal, Ahmed, et al.
Publicado: (2021)

The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL
por: Possati-Resende, Júlio C., et al.
Publicado: (2015)

Risk factors for cytological progression in HPV 16 infected women with ASC-US or LSIL: The Korean HPV cohort
por: So, Kyeong A, et al.
Publicado: (2018)

The value of Ki67 for the diagnosis of LSIL and the problems of p16 in the diagnosis of HSIL
por: Liu, Jixuan, et al.
Publicado: (2022)

Validation of an on-chip p16(ink4a)/Ki-67 dual immunostaining cervical cytology system using microfluidic device technology
por: Hashimoto, Kei, et al.
Publicado: (2023)

Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology
por: Ki, Eun Young, et al.
Publicado: (2019)

Predictive value of p16(INK4a), Ki-67 and ProExC immuno-qualitative features in LSIL progression into HSIL
por: Ding, Ling, et al.
Publicado: (2020)

Proliferating Trichilemmal Cyst: The Value Of Ki67 Immunostaining
por: Rangel-Gamboa, Lucia, et al.
Publicado: (2013)

Ki67 immunostaining in primary breast cancer: pathological and clinical associations.
por: Bouzubar, N., et al.
Publicado: (1989)

Successful Preventive Treatment of Oncogenic Transforming HPV Infections in Low-Grade Cytology (ASC-US/LSIL) Patients with an Adsorptive and Antioxidant Vaginal Gel
por: Major, Attila Louis, et al.
Publicado: (2023)

P16/Ki-67 Immunostaining is Useful in Stratification of Atypical Metaplastic Epithelium of the Cervix
por: Walts, Ann E., et al.
Publicado: (2008)

Ki-67 immunostaining in astrocytomas: Association with histopathological grade – A South Indian study
por: Shivaprasad, Nandish Vastrad, et al.
Publicado: (2016)

Role of p16/Ki-67 Dual Immunostaining in Detection of Cervical Cancer Precursors
por: Das, Diya, et al.
Publicado: (2018)

The Diagnostic Utility of p16 Immunostaining in Differentiating Cancer and HSIL from LSIL and Benign in Cervical Cells
por: Wu, Ming-Zhe, et al.
Publicado: (2018)

The Role of p16/Ki-67 Immunostaining, hTERC Amplification and Fibronectin in Predicting Cervical Cancer Progression: A Systematic Review
por: Voidăzan, Septimiu Toader, et al.
Publicado: (2022)

Cytological, Colposcopic and Pathohistological Correlation of HSIL and ASC H Findings
por: Jahic, Mahira, et al.
Publicado: (2020)

p16(INK4a)/Ki-67 dual stain cytology for cervical cancer screening in Thika district, Kenya
por: Ngugi, Caroline Wangari, et al.
Publicado: (2015)

Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM
por: Serrano-Villar, Sergio, et al.
Publicado: (2017)

A semi-automated microscopic image analysis method for scoring Ki-67 nuclear immunostaining
por: Fernezlian, S.M., et al.
Publicado: (2023)

Safety Run-in of Intramuscular pNGVL4a-Sig/E7(detox)/HSP70 DNA and TA-CIN Protein Vaccination as Treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1
por: Einstein, Mark H., et al.
Publicado: (2023)

Diagnostic Accuracy of p16(INK4a)/Ki-67 Dual Immunostaining for Detection of High-Grade Cervical Intraepithelial Neoplasia in Women Involved in Cervical Cancer Screening in Georgia
por: Kakaliashvili-Dzagnidze, Sopio, et al.
Publicado: (2023)

Automated Immunostaining Platform in Cytology
por: Sharma, Shelly, et al.
Publicado: (2021)

Evaluation of p16/Ki-67 Dual Staining Compared with HPV Genotyping in Anal Cytology with Diagnosis of ASC-US for Detection of High-Grade Anal Intraepithelial Lesions
por: Pichon, Maxime, et al.
Publicado: (2019)

Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
por: Choi, Soon Bo, et al.
Publicado: (2022)

Diagnostic utility of Ki-67 and Cyclin D1 immunostaining in differentiation of psoriasis vs. other psoriasiform dermatitis
por: Sezer, Engin, et al.
Publicado: (2015)

The Diagnostic Value of p16/Ki67 Dual Immunostaining for Anal Intraepithelial Neoplasia: A Meta-Analysis
por: Chen, Cheng-Chieh, et al.
Publicado: (2020)

The Role of P16, P53, KI-67 and PD-L1 Immunostaining in Primary Vaginal Cancer
por: Egger, Eva K., et al.
Publicado: (2023)

Performance of p16/Ki67 Immunostaining for Triage of Elderly Women with Atypical Squamous Cells of Undetermined Significance
por: Bruno, Maria Teresa, et al.
Publicado: (2023)

The Utility of p16INK4a and Ki-67 as a Conjunctive Tool in Uterine Cervical Lesions
por: Lee, Sangho, et al.
Publicado: (2012)

P16 and Ki67 Immunostains Decrease Intra- and Interobserver Variability in the Diagnosis and Grading of Anal Intraepithelial Neoplasia (AIN)
por: Walts, Ann E., et al.
Publicado: (2008)

Re-evaluation of Negative Cone Biopsy Results with Ki-67 and p16 Immunostaining following Positive Cervical Biopsy
por: Sari Aslani, Fatemeh, et al.
Publicado: (2020)

Utility of P16/INK4a and Ki-67 in Preneoplasticand Neoplastic Lesions of Cervix
por: Sangwaiya, Ashok, et al.
Publicado: (2018)

Application of p16/Ki-67 dual-staining cytology in cervical cancers
por: Yu, Li, et al.
Publicado: (2019)

Comparison of [(3)H]-Thymidine, Carboxyfluorescein Diacetate Succinimidyl Ester and Ki-67 in Lymphocyte Proliferation
por: Lee, Hsin-Ju, et al.
Publicado: (2022)

The gray zone squamous lesions: ASC-US / ASC-H
por: Kattoor, Jayasree, et al.
Publicado: (2022)

Role of Dual-Staining p16/Ki-67 in the Management of Patients under 30 Years with ASC-US/L-SIL
por: Secosan, Cristina, et al.
Publicado: (2022)

Diagnostic Performance of p16/Ki-67 Dual Immunostaining at Different Number of Positive Cells in Cervical Smears in Women Referred for Colposcopy
por: Gajsek, Ursula Salobir, et al.
Publicado: (2021)

Evaluation of the Ki-67 and MCM3 Expression in Cytologic Smear of Oral Squamous Cell Carcinoma
por: Rezazadeh, Fahimeh, et al.
Publicado: (2017)

Novel concepts in cervical cancer screening: a comparison of VIA, HPV DNA test and p16(INK4a)/Ki-67 dual stain cytology in Western Kenya
por: Orang’o, Elkanah Omenge, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dmocn794omt8vgsq0tvd6upk4b